Rep. Gilbert Ray Cisneros, Jr. Sells CME Group Inc. (NASDAQ:CME) Shares

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of CME Group Inc. (NASDAQ:CME). In a filing disclosed on July 02nd, the Representative disclosed that they had sold between $1,001 and $15,000 in CME Group stock on June 16th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of The Descartes Systems Group (NASDAQ:DSGX) on 6/30/2026.
• Purchased $1,001 – $15,000 in shares of Texas Roadhouse (NASDAQ:TXRH) on 6/30/2026.
• Purchased $1,001 – $15,000 in shares of Texas Capital Bancshares (NASDAQ:TCBI) on 6/30/2026.
• Sold $1,001 – $15,000 in shares of SoftBank Group (OTCMKTS:SFTBF) on 6/30/2026.
• Sold $1,001 – $15,000 in shares of Semtech (NASDAQ:SMTC) on 6/30/2026.
• Sold $1,001 – $15,000 in shares of RBC Bearings (NYSE:RBC) on 6/30/2026.
• Purchased $1,001 – $15,000 in shares of Microchip Technology (NASDAQ:MCHP) on 6/30/2026.
• Purchased $1,001 – $15,000 in shares of HealthEquity (NASDAQ:HQY) on 6/30/2026.
• Purchased $1,001 – $15,000 in shares of Cytokinetics (NASDAQ:CYTK) on 6/30/2026.
• Sold $1,001 – $15,000 in shares of Credo Technology Group (NASDAQ:CRDO) on 6/30/2026.

CME Group Stock Performance

Shares of NASDAQ:CME remained flat at $236.60 on Friday. The stock had a trading volume of 4,625,547 shares, compared to its average volume of 4,107,516. The firm has a market capitalization of $85.73 billion, a price-to-earnings ratio of 20.19, a PEG ratio of 2.65 and a beta of 0.25. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The business has a 50-day moving average of $267.17 and a 200 day moving average of $284.28.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same period in the prior year, the business posted $2.80 EPS. The firm’s quarterly revenue was up 14.5% on a year-over-year basis. As a group, equities research analysts predict that CME Group Inc. will post 12.28 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were issued a $1.30 dividend. The ex-dividend date was Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.2%. CME Group’s dividend payout ratio (DPR) is currently 44.37%.

Analyst Upgrades and Downgrades

Several research firms have commented on CME. Deutsche Bank Aktiengesellschaft decreased their price target on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research report on Thursday, April 23rd. Raymond James Financial reiterated an “outperform” rating and set a $320.00 price objective on shares of CME Group in a research note on Thursday. JPMorgan Chase & Co. increased their target price on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research report on Thursday, April 16th. Erste Group Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, June 5th. Finally, Barclays cut their price target on shares of CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a report on Thursday, April 23rd. Twelve equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $300.94.

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard acquired 325 shares of the company’s stock in a transaction dated Thursday, June 25th. The shares were acquired at an average cost of $230.57 per share, with a total value of $74,935.25. Following the acquisition, the director directly owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the transaction, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This trade represents a 38.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On CME Group

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Norges Bank acquired a new position in CME Group during the 4th quarter valued at approximately $1,523,241,000. Sanders Capital LLC purchased a new stake in shares of CME Group during the third quarter valued at $1,006,932,000. Victory Capital Management Inc. increased its position in shares of CME Group by 746.4% in the 4th quarter. Victory Capital Management Inc. now owns 2,049,649 shares of the financial services provider’s stock valued at $559,720,000 after acquiring an additional 1,807,491 shares during the period. Bank of America Corp DE increased its position in shares of CME Group by 39.1% in the 1st quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider’s stock valued at $1,187,290,000 after acquiring an additional 1,130,587 shares during the period. Finally, Life Cycle Investment Partners Ltd purchased a new position in CME Group in the 4th quarter worth $217,656,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.